Search Page

1

Cite

Share

NRF2 in human neoplasm: Cancer biology and potential therapeutic target.

Liu Y, Lang F, Yang C. Liu Y, et al. Pharmacol Ther. 2021 Jan;217:107664. doi: 10.1016/j.pharmthera.2020.107664. Epub 2020 Aug 15. Pharmacol Ther. 2021. PMID: 32810525 Review.

Cite

Share

2

Cite

Share

Mitochondrial complex II and reactive oxygen species in disease and therapy.

Hadrava Vanova K, Kraus M, Neuzil J, Rohlena J. Hadrava Vanova K, et al. Redox Rep. 2020 Dec;25(1):26-32. doi: 10.1080/13510002.2020.1752002. Redox Rep. 2020. PMID: 32290794 Free PMC article. Review.

Cite

Share

3

Cite

Share

Precision Medicine in Phaeochromocytoma and Paraganglioma.

Winzeler B, Challis BG, Casey RT. Winzeler B, et al. J Pers Med. 2021 Nov 22;11(11):1239. doi: 10.3390/jpm11111239. J Pers Med. 2021. PMID: 34834591 Free PMC article. Review.

Cite

Share

4

Cite

Share

Reactive Oxygen Species: A Promising Therapeutic Target for SDHx-Mutated Pheochromocytoma and Paraganglioma.

Hadrava Vanova K, Yang C, Meuter L, Neuzil J, Pacak K. Hadrava Vanova K, et al. Cancers (Basel). 2021 Jul 27;13(15):3769. doi: 10.3390/cancers13153769. Cancers (Basel). 2021. PMID: 34359671 Free PMC article.

Cite

Share

5

Cite

Share

Targeting the Redox Balance Pathway Using Ascorbic Acid in sdhb Zebrafish Mutant Larvae.

Dona M, Lamers M, Rohde S, Gorissen M, Timmers HJLM. Dona M, et al. Cancers (Basel). 2021 Oct 13;13(20):5124. doi: 10.3390/cancers13205124. Cancers (Basel). 2021. PMID: 34680273 Free PMC article.

Cite

Share

6

Cite

Share

The Role of Iron in Cancer Progression.

Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W, Zheng L, Li X. Guo Q, et al. Front Oncol. 2021 Nov 10;11:778492. doi: 10.3389/fonc.2021.778492. eCollection 2021. Front Oncol. 2021. PMID: 34858857 Free PMC article. Review.

Cite

Share

7

Cite

Share

Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate.

Goncalves J, Moog S, Morin A, Gentric G, Müller S, Morrell AP, Kluckova K, Stewart TJ, Andoniadou CL, Lussey-Lepoutre C, Bénit P, Thakker A, Vettore L, Roberts J, Rodriguez R, Mechta-Grigoriou F, Gimenez-Roqueplo AP, Letouzé E, Tennant DA, Favier J. Goncalves J, et al. Cancer Res. 2021 Jul 1;81(13):3480-3494. doi: 10.1158/0008-5472.CAN-20-2936. Epub 2021 Jun 14. Cancer Res. 2021. PMID: 34127497 Free article.

Cite

Share

8

Cite

Share

Reversible Regulation of Succinate Dehydrogenase by Tools of Photopharmacology.

Fu W, Shao Z, Sun X, Zhou C, Xu Z, Zhang Y, Cheng J, Li Z, Shao X. Fu W, et al. J Agric Food Chem. 2022 Apr 13;70(14):4279-4290. doi: 10.1021/acs.jafc.1c08198. Epub 2022 Mar 31. J Agric Food Chem. 2022. PMID: 35357145

Cite

Share

9

Cite

Share

High-specific-activity ¹³¹iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma.

Dillon JS, Bushnell D, Laux DE. Dillon JS, et al. Future Oncol. 2021 Apr;17(10):1131-1141. doi: 10.2217/fon-2020-0625. Epub 2021 Jan 28. Future Oncol. 2021. PMID: 33506713 Free PMC article.

Cite

Share

10

Cite

Share

Model systems in SDHx-related pheochromocytoma/paraganglioma.

Takács-Vellai K, Farkas Z, Ősz F, Stewart GW. Takács-Vellai K, et al. Cancer Metastasis Rev. 2021 Dec;40(4):1177-1201. doi: 10.1007/s10555-021-10009-z. Epub 2021 Dec 27. Cancer Metastasis Rev. 2021. PMID: 34957538 Free PMC article. Review.

Cite

Share